• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过人 IgG 适体复合物的 2.15 A 晶体结构揭示了 RNA 对靶标识别的构象可塑性。

Conformational plasticity of RNA for target recognition as revealed by the 2.15 A crystal structure of a human IgG-aptamer complex.

机构信息

Department of Life and Environmental Sciences, Faculty of Engineering, Chiba Institute of Technology, Narashino-shi, Chiba 275-0016, Japan.

出版信息

Nucleic Acids Res. 2010 Nov;38(21):7822-9. doi: 10.1093/nar/gkq615. Epub 2010 Jul 30.

DOI:10.1093/nar/gkq615
PMID:20675355
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2995045/
Abstract

Aptamers are short single-stranded nucleic acids with high affinity to target molecules and are applicable to therapeutics and diagnostics. Regardless of an increasing number of reported aptamers, the structural basis of the interaction of RNA aptamer with proteins is poorly understood. Here, we determined the 2.15 Å crystal structure of the Fc fragment of human IgG1 (hFc1) complexed with an anti-Fc RNA aptamer. The aptamer adopts a characteristic structure fit to hFc1 that is stabilized by a calcium ion, and the binding activity of the aptamer can be controlled many times by calcium chelation and addition. Importantly, the aptamer-hFc1 interaction involves mainly van der Waals contacts and hydrogen bonds rather than electrostatic forces, in contrast to other known aptamer-protein complexes. Moreover, the aptamer-hFc1 interaction involves human IgG-specific amino acids, rendering the aptamer specific to human IgGs, and not crossreactive to other species IgGs. Hence, the aptamer is a potent alternative for protein A affinity purification of Fc-fusion proteins and therapeutic antibodies. These results demonstrate, from a structural viewpoint, that conformational plasticity and selectivity of an RNA aptamer is achieved by multiple interactions other than electrostatic forces, which is applicable to many protein targets of low or no affinity to nucleic acids.

摘要

适体是具有与靶分子高亲和力的短单链核酸,适用于治疗和诊断。尽管越来越多的适体被报道,但 RNA 适体与蛋白质相互作用的结构基础仍了解甚少。在这里,我们确定了与人 IgG1(hFc1)Fc 片段复合物的抗 Fc RNA 适体的 2.15Å 晶体结构。该适体采用适合 hFc1 的特征结构,并通过钙离子稳定,并且通过钙螯合和添加可以多次控制适体的结合活性。重要的是,与其他已知的适体-蛋白质复合物相比,适体-hFc1 相互作用主要涉及范德华力和氢键,而不是静电力。此外,适体-hFc1 相互作用涉及人 IgG 特异性氨基酸,使适体特异性针对人 IgG,而不与其他物种 IgG 发生交叉反应。因此,该适体是 Fc 融合蛋白和治疗性抗体的蛋白 A 亲和纯化的有效替代品。这些结果从结构角度表明,RNA 适体的构象灵活性和选择性是通过除静电力以外的多种相互作用实现的,这适用于对核酸亲和力低或没有亲和力的许多蛋白质靶标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/fdae4d9e7747/gkq615f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/8364e47ff00e/gkq615f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/2c99e4e9cc69/gkq615f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/829d55322f7e/gkq615f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/fdae4d9e7747/gkq615f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/8364e47ff00e/gkq615f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/2c99e4e9cc69/gkq615f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/829d55322f7e/gkq615f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac3b/2995045/fdae4d9e7747/gkq615f4.jpg

相似文献

1
Conformational plasticity of RNA for target recognition as revealed by the 2.15 A crystal structure of a human IgG-aptamer complex.通过人 IgG 适体复合物的 2.15 A 晶体结构揭示了 RNA 对靶标识别的构象可塑性。
Nucleic Acids Res. 2010 Nov;38(21):7822-9. doi: 10.1093/nar/gkq615. Epub 2010 Jul 30.
2
Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G.RNA适配体对人免疫球蛋白G超特异性的结构和分子基础。
RNA. 2008 Jun;14(6):1154-63. doi: 10.1261/rna.1005808. Epub 2008 Apr 25.
3
Crystallization and preliminary X-ray diffraction studies of an RNA aptamer in complex with the human IgG Fc fragment.与人类IgG Fc片段复合的RNA适配体的结晶及初步X射线衍射研究。
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Oct 1;64(Pt 10):942-4. doi: 10.1107/S1744309108028236. Epub 2008 Sep 30.
4
Alkaline-tolerant RNA aptamers useful to purify acid-sensitive antibodies in neutral conditions.在中性条件下用于纯化酸敏感抗体的耐碱 RNA 适体。
Biochimie. 2018 Feb;145:113-124. doi: 10.1016/j.biochi.2017.10.025. Epub 2017 Nov 11.
5
Investigations on the interface of nucleic acid aptamers and binding targets.核酸适体与结合靶位界面的研究。
Analyst. 2018 Nov 5;143(22):5317-5338. doi: 10.1039/c8an01467a.
6
Crystallographic Pursuit of a Protein-RNA Aptamer Complex.蛋白质-RNA适配体复合物的晶体学研究
Methods Mol Biol. 2016;1380:151-60. doi: 10.1007/978-1-4939-3197-2_12.
7
Crystal structure of an RNA aptamer bound to thrombin.与凝血酶结合的RNA适配体的晶体结构。
RNA. 2008 Dec;14(12):2504-12. doi: 10.1261/rna.1239308. Epub 2008 Oct 29.
8
Characterization of aptamer-protein complexes by X-ray crystallography and alternative approaches.通过X射线晶体学及其他方法对适体-蛋白质复合物进行表征。
Int J Mol Sci. 2012;13(8):10537-10552. doi: 10.3390/ijms130810537. Epub 2012 Aug 22.
9
RNA aptamers specifically interact with the Fc region of mouse immunoglobulin G.RNA适配体与小鼠免疫球蛋白G的Fc区域特异性相互作用。
Nucleic Acids Symp Ser (Oxf). 2008(52):487-8. doi: 10.1093/nass/nrn247.
10
RNA plasticity and selectivity applicable to therapeutics and novel biosensor development.RNA 的可塑性和选择性可应用于治疗和新型生物传感器的开发。
Genes Cells. 2012 May;17(5):344-64. doi: 10.1111/j.1365-2443.2012.01596.x. Epub 2012 Apr 4.

引用本文的文献

1
Synthesis and structural analysis of dinucleotides containing 2',3'-trans-bridged nucleic acids with trans-5,6- or 5,7-fused ring skeleton.含有反式-5,6-或5,7-稠环骨架的2',3'-反式桥连核酸的二核苷酸的合成与结构分析。
Commun Chem. 2025 Mar 22;8(1):87. doi: 10.1038/s42004-025-01486-2.
2
Structural Insights into Protein-Aptamer Recognitions Emerged from Experimental and Computational Studies.从实验和计算研究中揭示出蛋白-适体识别的结构见解。
Int J Mol Sci. 2023 Nov 14;24(22):16318. doi: 10.3390/ijms242216318.
3
Therapeutic Potential of Aptamer-Protein Interactions.

本文引用的文献

1
RNA aptamers to translational components.翻译:靶向翻译组件的 RNA 适体。
Prog Mol Biol Transl Sci. 2009;90:369-95. doi: 10.1016/S1877-1173(09)90010-2. Epub 2009 Oct 27.
2
Crystal structure of an RNA aptamer bound to thrombin.与凝血酶结合的RNA适配体的晶体结构。
RNA. 2008 Dec;14(12):2504-12. doi: 10.1261/rna.1239308. Epub 2008 Oct 29.
3
Crystallization and preliminary X-ray diffraction studies of an RNA aptamer in complex with the human IgG Fc fragment.与人类IgG Fc片段复合的RNA适配体的结晶及初步X射线衍射研究。
适体-蛋白质相互作用的治疗潜力。
ACS Pharmacol Transl Sci. 2022 Nov 4;5(12):1211-1227. doi: 10.1021/acsptsci.2c00156. eCollection 2022 Dec 9.
4
Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases.针对淀粉样蛋白的适体及其在神经退行性疾病中的新兴作用。
J Biol Chem. 2022 Jan;298(1):101478. doi: 10.1016/j.jbc.2021.101478. Epub 2021 Dec 9.
5
SELEX: Critical factors and optimization strategies for successful aptamer selection.SELEX:成功的适体筛选的关键因素和优化策略。
Biotechnol Appl Biochem. 2022 Oct;69(5):1771-1792. doi: 10.1002/bab.2244. Epub 2021 Sep 3.
6
Aptamers isolated against mosquito-borne pathogens.针对蚊媒病原体分离的适配体。
World J Microbiol Biotechnol. 2021 Jul 9;37(8):131. doi: 10.1007/s11274-021-03097-0.
7
Multiple Therapeutic Applications of RBM-007, an Anti-FGF2 Aptamer.RBM-007,一种抗 FGF2 适体的多种治疗应用。
Cells. 2021 Jun 28;10(7):1617. doi: 10.3390/cells10071617.
8
Future Perspectives of Therapeutic, Diagnostic and Prognostic Aptamers in Eye Pathological Angiogenesis.治疗、诊断和预后适体在眼部病理性血管生成中的未来展望。
Cells. 2021 Jun 10;10(6):1455. doi: 10.3390/cells10061455.
9
Structural Biology for the Molecular Insight between Aptamers and Target Proteins.适体与靶蛋白之间分子洞察力的结构生物学。
Int J Mol Sci. 2021 Apr 15;22(8):4093. doi: 10.3390/ijms22084093.
10
Aptamers against Immunoglobulins: Design, Selection and Bioanalytical Applications.针对免疫球蛋白的适体:设计、选择和生物分析应用。
Int J Mol Sci. 2020 Aug 11;21(16):5748. doi: 10.3390/ijms21165748.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2008 Oct 1;64(Pt 10):942-4. doi: 10.1107/S1744309108028236. Epub 2008 Sep 30.
4
RNA folding: conformational statistics, folding kinetics, and ion electrostatics.RNA折叠:构象统计学、折叠动力学和离子静电学
Annu Rev Biophys. 2008;37:197-214. doi: 10.1146/annurev.biophys.37.032807.125957.
5
Structural and molecular basis for hyperspecificity of RNA aptamer to human immunoglobulin G.RNA适配体对人免疫球蛋白G超特异性的结构和分子基础。
RNA. 2008 Jun;14(6):1154-63. doi: 10.1261/rna.1005808. Epub 2008 Apr 25.
6
Aptamers as candidate therapeutics for cardiovascular indications.适体作为心血管适应症的候选治疗药物。
Curr Opin Pharmacol. 2008 Apr;8(2):147-52. doi: 10.1016/j.coph.2007.12.005. Epub 2008 Jan 28.
7
Sensing cellular magnesium with RNA.
Nat Chem Biol. 2007 Nov;3(11):693-4. doi: 10.1038/nchembio1107-693.
8
Protein aggregation and bioprocessing.蛋白质聚集与生物加工
AAPS J. 2006 Sep 15;8(3):E572-9. doi: 10.1208/aapsj080366.
9
RNA aptamers to mammalian initiation factor 4G inhibit cap-dependent translation by blocking the formation of initiation factor complexes.针对哺乳动物起始因子4G的RNA适体通过阻断起始因子复合物的形成来抑制帽依赖性翻译。
RNA. 2006 Oct;12(10):1825-34. doi: 10.1261/rna.2169406. Epub 2006 Aug 29.
10
Pegaptanib for the treatment of age-related macular degeneration.培加他尼用于治疗年龄相关性黄斑变性。
Exp Eye Res. 2006 Sep;83(3):615-9. doi: 10.1016/j.exer.2006.02.010. Epub 2006 May 4.